The budgetary impact of 2g mesalazine for the treatment of mild to moderate ulcerative colitis

Authors:

Lovelace I, Tate E, Knapp S, Masure J and Shields G.

Publication Type:

Conference Proceedings – Poster

Publication Name:

9th Congress of the European Crohn’s and Colitis Organisation

Citation:

Lovelace I, Tate E, Knapp S, Masure J and Shields G. The budgetary impact of 2g mesalazine for the treatment of mild to moderate ulcerative colitis. 9th Congress of the European Crohns and Colitis Organisation. Copenhagen, Denmark. 20-22 February 2014. Poster P325.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies